Medicine and Dentistry
Myocardial Infarction
100%
Coronary Artery Disease
83%
Diabetes
59%
Cardiovascular Risk
47%
Cardiovascular System
43%
Drug-Eluting Stent
42%
Percutaneous Coronary Intervention
38%
Brain Ischemia
34%
Coronary Angiography
33%
Hazard Ratio
32%
Cohort Analysis
31%
Population
31%
Cardiovascular Disease
29%
Atrial Fibrillation
27%
Diabetes Mellitus
27%
Heart Muscle Ischemia
26%
Heart Death
21%
Cause of Death
21%
Apoplexy
20%
Patient with Diabetes
18%
Maturity Onset Diabetes of the Young
16%
Cooperation
16%
Ischemic Heart Disease
16%
ST Segment Elevation Myocardial Infarction
15%
Stent Thrombosis
15%
Noncardiac Surgery
14%
Odds Ratio
13%
Major Adverse Cardiac Event
13%
Acute Coronary Syndrome
13%
Disease
12%
Heart Failure
12%
Statin
12%
Primary Percutaneous Coronary Intervention
12%
Cardiology
11%
Arteriosclerosis Obliterans
11%
Rheumatoid Arthritis
11%
Rapamycin
11%
Zotarolimus
11%
Chronic Kidney Disease
11%
Absence
10%
Anticoagulation
10%
Heart Muscle Revascularization
9%
Mortality
8%
Risk Stratification
8%
Stable Angina Pectoris
7%
Coronary Computed Tomography Angiography
7%
Prophylaxis
7%
Antithrombotic
7%
All Cause Mortality
7%
CHA2DS2-VASc Score
7%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Disease
99%
Heart Infarction
94%
Cardiovascular Risk
59%
Brain Ischemia
40%
Cardiovascular Disease
34%
Cohort Study
32%
Atrial Fibrillation
27%
Heart Muscle Ischemia
23%
ST Segment Elevation Myocardial Infarction
22%
Heart Failure
21%
Ischemic Heart Disease
20%
Coronary Artery Atherosclerosis
20%
Disease
19%
Heart Death
19%
Statin (Protein)
19%
Non Insulin Dependent Diabetes Mellitus
17%
Diabetes Mellitus
17%
All Cause Mortality
17%
Acetylsalicylic Acid
15%
Cause of Death
15%
Anticoagulant Agent
12%
High Density Lipoprotein Cholesterol
11%
Rheumatoid Arthritis
11%
Chronic Kidney Failure
11%
Absence
8%
Stable Angina Pectoris
8%
Stent Thrombosis
7%
Acute Heart Infarction
7%
Peripheral Occlusive Artery Disease
6%
Low Density Lipoprotein Cholesterol
6%
Retrospective Study
6%
Rivaroxaban
6%
Bleeding
6%
Thromboembolism
6%
Autoimmune Disease
5%
Ticagrelor
5%
Monotherapy
5%
Cardiovascular Mortality
5%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
5%
Keyphrases
Denmark
11%
All-cause Mortality
7%
10-year Mortality
6%
Myocardial Infarction
5%
Left Ventricular Ejection Fraction
5%
Pooled Cohorts
5%
Coronary Stent Implantation
5%
Confidence Interval
5%
Newly Diagnosed
5%
Cardiovascular Outcomes
5%
Strong Predictor
5%
Individual Participant Data
5%
Optical Coherence Tomography
5%
Non-obstructive
5%
Chronic Coronary Syndrome
5%
Baseline Risk
5%
Heart Failure
5%
Net Clinical Benefit
5%
Anticoagulation Strategy
5%
Lower Extremity Revascularization
5%
Autoimmune Disease
5%
Coronary Artery Disease
5%
Coronary Atherosclerosis
5%
Ischemic Events
5%
Cardiovascular Risk Assessment
5%
Sudden Cardiac Death
5%
Thrombus
5%
Dual Pathway Inhibition
5%
Left Ventricular Function
5%
Ejection Fraction
5%
Population-based
5%
Registry-based
5%
National Health Registry
5%
Registry Study
5%
Type 2 Diabetes Mellitus (T2DM)
5%
